Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Combined neuroendocrine carcinoma and adenocarcinoma in the stomach: A case report

Combined neuroendocrine carcinoma and adenocarcinoma in the stomach: A case report Neuroendocrine carcinoma and adenocarcinoma existing in the stomach simultaneously is extremely rare. This report presents a 65‑year‑old male patient who was diagnosed with three types of malignant tumors in the stomach, neuroendocrine carcinoma (NEC), moderately differentiated adenocarcinoma and mucinous adenocarcinoma. In addition, the NEC and moderately differentiated adenocarcinoma existed in the same lesion and, therefore, was referred to as a mixed adenocarcinoma ‑ NEC tumor. The patient underwent laparoscopic‑assisted D2 radical total gastrectomy, Roux‑en‑Y esophagus‑jejunum anastomosis and received FOLFOX chemotherapy for six cycles 3 weeks after surgery. Follow‑up determined that the patient survived and was tumor‑free 12 months after surgery. In conclusion, radical surgery combined with chemotherapy can effectively improve the prognosis of patients with these three specific tumor types simultaneously in the stomach. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology Letters Spandidos Publications

Combined neuroendocrine carcinoma and adenocarcinoma in the stomach: A case report

Loading next page...
 
/lp/spandidos-publications/combined-neuroendocrine-carcinoma-and-adenocarcinoma-in-the-stomach-a-eUGfAk0Lqo

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Spandidos Publications
Copyright
Copyright © Spandidos Publications
ISSN
1792-1074
eISSN
1792-1082
DOI
10.3892/ol.2014.1825
Publisher site
See Article on Publisher Site

Abstract

Neuroendocrine carcinoma and adenocarcinoma existing in the stomach simultaneously is extremely rare. This report presents a 65‑year‑old male patient who was diagnosed with three types of malignant tumors in the stomach, neuroendocrine carcinoma (NEC), moderately differentiated adenocarcinoma and mucinous adenocarcinoma. In addition, the NEC and moderately differentiated adenocarcinoma existed in the same lesion and, therefore, was referred to as a mixed adenocarcinoma ‑ NEC tumor. The patient underwent laparoscopic‑assisted D2 radical total gastrectomy, Roux‑en‑Y esophagus‑jejunum anastomosis and received FOLFOX chemotherapy for six cycles 3 weeks after surgery. Follow‑up determined that the patient survived and was tumor‑free 12 months after surgery. In conclusion, radical surgery combined with chemotherapy can effectively improve the prognosis of patients with these three specific tumor types simultaneously in the stomach.

Journal

Oncology LettersSpandidos Publications

Published: Apr 1, 2014

There are no references for this article.